Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission ...
Aug 9, 2023
0
2
New research led by scientists working with Georgia State University's TReNDS Center has identified age-related changes in brain patterns associated with the risk for developing schizophrenia.
Aug 2, 2023
0
45
Psyllium fiber protects against ulcerative colitis and suppresses inflammation by activating the bile acid nuclear receptor, a mechanism that was previously unrecognized, according to a new study by researchers in the Institute ...
Feb 23, 2023
0
287
A measure of brain activity known as causal flow can help locate the source of seizures before they occur, according to a new study co-authored by Georgia State and Emory University researchers.
Jan 19, 2023
0
3
As a surge in cases of respiratory syncytial virus, or RSV, continues pushing hospitals to capacity across the U.S., researchers at Georgia State's Institute for Biomedical Sciences are working to develop vaccines and other ...
Jan 6, 2023
0
8
Leading e-cigarette researchers are urging the U.S. Centers for Disease Control & Prevention (CDC) to correct misinformation overstating the dangers of e-cigarettes as part of its "Moving Forward" initiative.
Dec 14, 2022
0
6
Two years into the pandemic, U.S. counties with lower home internet or computer access levels were seeing higher COVID-19 case and death rates, according to research by Fei Li, an assistant professor of urban studies at Georgia ...
Dec 14, 2022
0
12
A web-based app shows potential for advancing the communication skills of children with developmental disorders in low- and middle-income countries, according to a recent study co-authored by Georgia State University researchers.
Oct 13, 2022
0
11
A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
Aug 25, 2022
1
141
SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers ...
Aug 1, 2022
0
37
